The combined effects of allz-trans retinoic acid and TGF-β on the initial proliferation of normal human bone marrow progenitor cells

Leukemia

Volumn 10, Issue 12, 1996, Pages 1937-1943

  Lardon, F ^a   Snoeck, H W ^a   Haenen, L ^a   Lenjou, M ^a   Nijs, C ^a   Weekx, S F A ^a   Van Ranst, P C F ^a   Berneman, Z N ^a,b   Van Bockstaele, D R ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

CD34; Cell cycle kinetics; Hematopoiesis; Retinoic acid; Transforming growth factor

Indexed keywords

BROXURIDINE; INTERLEUKIN 3; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030448014     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417-428.
2. 1, is an inducer of erythroid differentiation. J Exp Med 1994; 180: 851-860.
3. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth-β gene family members and bone. Endocrin Rev 1994; 15: 27-29.
4. Roberts AB, Flanders KC, Kondaiah P, Thompson NL, Van Obberghen-Shilling E, Wakefield L, Rossi P, de Crombrugghe B, Heine U, Sporn MB. Transforming growth factor β: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Rec Prog Horm Res 1988; 44: 157-197.
5. Keller JR, Jacobsen SE, Dubois CM, Hestdal K, Ruscetti FW. Transforming growth factor-β: a bidirectional regulator of hematopoietic cell growth, Int J Cell Clon 1992; 10: 2-11.
6. Kishi K, Ellingsworth LR, Ogawa M. The suppressive effects of type β transforming growth factor (YGFβ) on primitive murine hemopoietic progenitors are abrogated by interleukin-6 and granulocyte colony-stimulating factor. Leukemia 1989; 3: 687-691.
7. Ruscetti FW, Dubois CM, Jacobsen SE, Keller JR. Transforming growth factor βand interleukin-1: a paradigm for opposing regulation of haemopoiesis. In: Lord BI, Dexter TM (eds). Baillière's Clinical Haematology, Vol. 5 Number 3, WB Saunders: London, 1992, pp 703-721.
8. 1, effects by cytokines. Immunol Invest 1993; 22: 375-388.
9. + human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp Hematol 1994; 22: 903-909.
10. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological functions and chemical structure. Science 1986; 233: 532-534.
11. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987; 105: 966-975.
12. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
13. Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentation, and cellular oncogene expression. Blood 1987; 70: 1233-1244.
14. De Benedetti F, Falk LA, Ellingsworth LR, Ruscetti FW, Faltynek CR. Synergy between transforming growth factor-β and tumor necrosis factor-α in the induction of monocytic differentiation of human leukemic cell lines. Blood 1990; 75: 626-632.
15. 1-mediated autocrine inhibition. Blood 1991; 77: 1248-1255.
16. Hooper WC. The role of transforming growth factor-β in hematopoiesis. A review. Leukemia Res 1991; 15: 179-184.
17. Keller JR, Sing GK, Ellingsworth LR, Ruscetti FW. Transforming growth factor-β: possible roles in the regulation of normal and leukemic hematopoietic cell growth. J Cell Biochem 1989; 39: 175-184.
18. Ottmann OG, Pelus LM. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J Immunol 1988; 140: 2661-2665.
19. 1, with hematopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol 1989; 17: 296-299.
20. + BM cells. Ann Hematol 1993; 66: 61-66.
21. Gratas C, Menot ML, Dresch C, Chomienne C. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marow cells. Leukemia 1993; 7: 1156-1162.
22. Van Bockstaele DR, Lenjou M, Snoeck H-W, Lardon F, Peetermans ME. Effect of retinoic acid (RA) on myeloid progenitors in normal bone marrow (BM). Leukemia 1994; 8: 214-215.
23. Jacobsen SE, Fahlman C, Blomhoff HK, Okkenhaug C, Rusten LS, Smeland EB. All-trans and 9-cis retinoic acid: potent inhibitors of primitive murine hematopoietic progenitors in vitro. J Exp Med 1994; 179: 1665-1670.
24. Kubbies M, Hoehn H, Schindler D, Chen YC, Rabinovitch PS. Cell cycle analysis via BrdU-Hoechst flow cytometry - principles and applications. In: Yen A (ed). Flow Cytometry: Advanced Research and Clinical Applications. CRC Press: Boca Raton, FL, 1989, pp 5-28.
25. Van Bockstaele DR, Lardon F, Snoeck H-W, Peetermans ME. BrdU-Hoechst-ethidium bromide (EB) quenching technique for studying kinetics of hematopoiesis. Blood 1992; 80: 289-291.
26. + bone marrow cells in relation to their colony formation. Blood 1993; 81: 3211-3216.
27. Rabinovitch PS, Kubbies M, Chen YC, Schindler D, Hoehn H. BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis, Exp Cell Res 1988; 174: 309-318.
28. ckil) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells, Leukemia 1991; 5: 854-860.
29. Douer D, Koeffler HP. Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cell in vitro. Exp Cell Res 1982; 138: 193-198.
30. Tohda S, Minden MD, McCulloch EA. Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia. Leukemia 1991; 5: 951-957.
31. Cillo C, Sekaly RP, Magli MC, Odartchenko N. Early hemopoietic progenitor cells: direct measurement of cell cycle status. Ann NY Acad Sci 1985; 459: 150-161.
32. Rizzino A. Appearance of high affinity receptors for type β transforming growth factor during differentiation of murine embryonal carcinoma cells. Cancer Res 1987; 47: 4386-4390.
33. 2 in cultured keratinocytes and mouse epidermis. Cell Regul 1989; 1: 87-97.
34. Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ. A clinical and experimental study on alltrans retinoic acid-treated acute promyelocytic leukemia. Leukemia 1991; 5: 200-204.
35. Clark RE, Jacobs A, Lush CJ, Smith SA. Effects of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome. Lancet 1987; 1: 763-765.
36. Bonewald LF. Can transforming growth factor beta be useful as a protective agent for pluripotent hematopoietic progenitor cells? Exp Hematol 1992; 20: 1249-1251.
37. Lemoli RM, Strife A, Clarkson BD, Haley JD, Gulati SC. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro. Exp Hematol 1992; 20: 1252-1256.
38. 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J Exp Med 1994; 180: 1047-1057.